2024 BioMAN Summit

Artificial Intelligence in Biomanufacturing

The 2024 BioMAN Summit will be conducted as a hybrid event, featuring discussions on:

Artificial Intelligence(AI); including techniques such as machine learning (ML), deep learning (DL), and natural language processing (NLP); has the potential to transform the way biologic medicines are manufactured. FDA reported that in 2021 alone, over 100 new drug and biologic license application submissions contained the use of AI and ML, with the areas of AI/ML applications panning the entire product development pipeline, from drug development to post-market surveillance. While FDA continues to develop the regulatory framework for using AI in biomanufacturing, industry must itself prepare their organizations to take advantage of the opportunities presented by these new tools. As AI applications become more common in biological drug manufacturing, it will also be critically important to ensure that this new technology is being applied correctly by a well-trained work forces, especially as it is used in novel indications.

This Summit will address topics such as:

– How are AI and its associated techniques currently being used in biomanufacturing?

– What have been the main challenges to implementing AI and ML, and how has the industry overcome them?

– What are the most promising future applications of AI in biomanufacturing in both the near and long terms?

– How can the industry ensure there is a well-trained AI workforce that is integrated into manufacturing operations?

– How are regulatory and industry bodies supporting AI in biomanufacturing and what opportunities remain for increased cooperation

Register here to secure your spot for the 2024 BioMAN Summit and explore how Artificial Intelligence is revolutionizing biologic medicines’ manufacturing processes. Gain insights into AI techniques like machine learning, deep learning, and natural language processing, and understand their impact on product quality control and development.